Community

We are seeking a highly motivated and innovative research associate with experience in molecular biology, cell biology, and immunology. The successful candidate will contribute as part of a multidisciplinary team to improve gene-editing based therapeutics by developing techniques and researching new cutting-edge topics applied to T cell biology. The successful candidate is expected to have proven practical experience in performing and analyzing relevant data sets from mammalian cell culture and or animal models using standard immunological techniques such as flow cytometry. T cell handling and/or cell culture experience in primary cells is expected. The candidate should be scientifically motivated, capable of independently conceiving, conducting, critically analyzing and presenting his/her own innovative research with minimal supervision. Strong presentation skills, communication, and the ability to work in a fast-paced and team-oriented environment is vital.

Editas Medicine is a transformative genome editing company with a mission to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level. 

We are seeking a highly motivated and innovative Associate Scientist to join Editas Medicine as a member of the Technical Development and Manufacturing team.  The successful candidate will contribute to Process Development for the clinical manufacture of CRISPR ribonucleoprotein complexes (RNPs).  The primary responsibilities of this role will be to conduct RNP complexation, formulation, and stability studies.  Prior experience working with purified proteins and/or nucleic acids is a must.  Strong communication skills, rigorous documentation practices, and the ability to work in a fast-paced and team-oriented environment will also be vital.

Key Responsibilities:

• Support development of clinically-appropriate CRISPR RNP manufacturing processes
• Perform CRISPR RNP formulations and stability studies
• Collaborate with Analytical Development team to monitor biochemical, biophysical, and biological properties of CRISPR RNPs
• Compile/analyze experimental data and present project updates to cross-functional teams
• Record results in electronic lab notebooks (ELN) and prepare technical reports

Editas Medicine is a transformative genome editing company with a mission to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level.   

We are seeking a highly motivated and innovative research associate with analytical chemistry or bioanalytical expertise to support the development of gene editing-based therapies. The successful candidate will contribute as part of a dynamic, multidisciplinary discovery team dedicated to the development of a novel class of therapeutics. The successful candidate is expected to have proven practical experience in chemistry or biochemistry, specifically in purification and analysis of RNA and RNA derivatives. The candidate should be a scientifically motivated self-starter, capable of working with minimal supervision. Strong communication skills, and the ability to work in a fast-paced and team-oriented environment will also be vital.   

Location - Cambridge, MA

Editas Medicine is a transformative genome editing company with a mission to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective genome level molecular modification to treat the underlying cause of a broad range of diseases.

This new role on the Technical Development and Manufacturing team provides a unique opportunity to contribute to Editas efforts to develop safe and effective cellular therapies using CRISPR-based gene editing technologies. We are seeking a talented and highly-motivated individual to develop assays that generate data to guide development of analytical methods and standard operating procedures (SOPs) for the preparation of cellular therapies for translational clinical studies. Candidate must be versatile with extensive experience involving analytical characterization and cellular based products and the ability to work with research colleagues to develop analytical methods for cellular products derived from different lineages of cells (T cells, HSCs, etc.).

Key Responsibilities:

·         Work within a cross-functional team to develop cellular assays to support gene-edited cell therapy programs at Editas, with a focus on development of flow cytometry panels

·         Conduct hands-on laboratory research activities to develop analytical test methods for cellular in-process and release testing to support manufacturing for clinical trials

·         Write test methods,  develop controls, trend... More Info

Location - Cambridge, MA

Editas Medicine is a transformative genome editing company with a mission to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective genome level molecular modification to treat the underlying cause of a broad range of diseases.

This new role on the Technical Development and Manufacturing team provides a unique opportunity to contribute to Editas efforts to develop safe and effective cellular therapies using CRISPR-based gene editing technologies. We are seeking a talented and highly-motivated individual to develop assays that generate data to guide development of analytical methods and standard operating procedures (SOPs) for the preparation of cellular therapies for translational clinical studies. Candidate must be versatile with extensive experience involving analytical characterization and cellular based products and the ability to work with research colleagues to develop analytical methods for cellular products derived from different lineages of cells (T cells, HSCs, etc.).

Key Responsibilities:

·         Work within a cross-functional team to develop cellular assays to support gene-edited cell therapy programs at Editas, with a focus on development of flow cytometry panels

·         Conduct hands-on laboratory research activities to develop analytical test methods for cellular in-process and release testing to support manufacturing for clinical trials

·         Write test methods,  develop controls, trend... More Info

Location - Cambridge, MA

Editas Medicine is a transformative genome editing company with a mission to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective genome level molecular modification to treat the underlying cause of a broad range of diseases.

This new role on the Technical Development and Manufacturing team provides a unique opportunity to contribute to Editas efforts to develop safe and effective cellular therapies using CRISPR-based gene editing technologies. We are seeking a talented and highly-motivated individual to develop assays that generate data to guide development of analytical methods and standard operating procedures (SOPs) for the preparation of cellular therapies for translational clinical studies. The successful candidate will work closely with the process development teams on diverse products and starting materials, including RNAs, proteins and cell therapies. They will also work cross-functionally with internal project and platform research teams, with external partners, and with CMOs to design in vitro bioassays and molecular assay panels to support process development, product release and stability.

Key Responsibilities:

·         Transfer in vitro activity assays, including cell-based assays, from the Platform and Pipeline teams into the Development organization

·         Develop suitable phase-appropriate potency assays for product release and stability testing

·         Conduct hands-on laboratory research activities to... More Info

Editas Medicine is a transformative genome editing company with a mission to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective genome level molecular modification to treat the underlying cause of a broad range of diseases.

This new role on the Technical Development and Manufacturing team provides a unique opportunity to contribute to Editas efforts to develop safe and effective cellular therapies using CRISPR-based gene editing technologies. We are seeking a talented and highly-motivated individual to develop assays that generate data to guide development of analytical methods and standard operating procedures (SOPs) for the preparation of cellular therapies for translational clinical studies. The successful candidate will work closely with the process development teams on diverse products and starting materials, including RNAs, proteins and cell therapies. They will also work cross-functionally with internal project and platform research teams, with external partners, and with CMOs to design in vitro bioassays and molecular assay panels to support process development, product release and stability.

Key Responsibilities:

·         Transfer in vitro activity assays, including cell-based assays, from the Platform and Pipeline teams into the Development organization

·         Develop suitable phase-appropriate potency assays for product release and stability testing

·         Conduct hands-on laboratory research activities to develop analytical test methods for in-process and release... More Info

This is an exciting opportunity to join Editas Medicine, a transformative genome editing company with a mission to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level. The Pharmacology group in Preclinical Science is seeking a highly talented and motivated Scientist I/II who will be responsible for designing and conducting in-life imaging and functional tests in support of development of novel CRISPR/Cas9-based therapeutics for Ophthalmology indications and other disease areas. This individual will work collaboratively with internal multi-disciplinary team members and external partners to drive and deliver results to support preclinical and clinical development initiatives. The position will report directly to the Associate Director of Preclinical Pharmacology.

Key Responsibilities:

·         Extensive hands-on experience in ocular imaging and surgical techniques and use of ophthalmic equipment.

·         In-depth knowledge of functional and structural endpoint measurements of retinas using optical coherence tomography (OCT), electroretinograms (ERGs), ocular fundus photography, fluorescein angiography, and slit lamp biomicrography.

·         Experience with animal models of inherited retinal disorders and use of gene therapy vectors to treat these disorders is required.

·         More Info

Editas Medicine is a transformative genome editing company with a mission to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level.

We are seeking an experienced program management professional to serve as Program Leader for one or more of Editas’ development programs. The ideal candidate will have a strong scientific background and experience developing drugs in the Gene Therapy, SiRNA Rare Disease, Immunology or Oncology space and leverage that experience to play a key role on Editas’ cross-functional teams, helping to translate scientific ideas into new medicines for patients. This role is highly cross-functional and will report to the Vice President, Program Management.

Key Responsibilities:

·        Serve as Program Leader... More Info

Editas is seeking a versatile and highly-motivated business analyst to lead key business development and strategic finance activities. The ideal candidate is a self-starter; able to quickly learn and apply new knowledge in a fast-paced environment. The Business Analyst will conduct assessments to enable business development and strategic capital allocation and be responsible for competitive intelligence activities involving Editas Medicine programs, competitors, and potential partners. This position will be an integral part of the finance organization and directly support the business development and strategic finance teams.

Key Responsibilities:

·         Develop assessments for business development and strategic finance initiatives

·         Prepare analyses of financial data and industry deals

·         Solicit appropriate inputs and build valuation and financial models in support of business development

·         Support diligence and deal negotiations by providing business analysis as directed

·         Gather and analyze primary competitive intelligence from medical conferences, industry conferences, key opinion leaders, and other primary resources

·More Info

Location - Cambridge, MA

Editas Medicine is a transformative genome editing company with a mission to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective genome level molecular modification to treat the underlying cause of a broad range of diseases.

This new role on the Technical Development and Manufacturing team provides a unique opportunity to contribute to Editas efforts to develop safe and effective cellular therapies using CRISPR-based gene editing technologies. We are seeking a talented and highly-motivated individual to design and perform experiments that generate data to guide development of methods and standard operating procedures (SOPs) for the preparation of cellular therapies for translational clinical studies. Candidate must be versatile and able to work with research colleagues to develop processes for autologous or normal donor cellular products derived from different lineages of cells (T cells, HSCs etc.).  

Key Responsibilities:

·         Lead cross functional team to develop cellular processes to support gene-edited cell therapy programs at Editas

·         Develop manufacturing SOPs for cellular products to support clinical testing

·         Work with Analytical team to generate and analyze data to develop understanding of most relevant critical quality attributes of cellular products to guide safe and effective clinical testing

More Info

Location – Boulder, CO

Editas Medicine is a transformative genome editing company with a mission to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level.   

We are seeking an innovative research associate with experience in organic chemistry to join the Medicinal Chemistry effort and support the development of gene editing-based therapies. The successful candidate will contribute as part of a dynamic, multidisciplinary discovery team dedicated to the development of a novel class of therapeutics. The successful candidate is expected to have proven experience in synthetic chemistry as demonstrated by peer reviewed publications or presentations at professional conferences.  Special consideration will be given to candidates with knowledge in the synthesis and analysis of RNA and RNA derivatives.  Those who are highly motivated self-starters and capable of working with minimal supervision are encouraged to apply. In our fast-paced environment possessing excellent communications skills and the ability to work effectively as part of a team will be vital.

The Associate, Director, Clinical Operations will provide strategic input and operational expertise to the Clinical Development Plans supporting the overall clinical strategy. The Associate Director is responsible for the planning, implementation, and conduct of clinical trials. The Associate Director is accountable for the day-to-day operations of clinical trials including, but not limited to, feasibility, study start up, enrollment, and close out activities. The Associate Director will manage the clinical project team members to ensure adherence to overall project timelines and budget. 

Key Responsibilities:

Clinical Trial Management

·         Serve as the clinical point person managing protocol execution, including the oversight of contract research organizations (CROs), vendors, and consultants that are involved with the clinical trial.

·         Partner with the Medical Lead to develop high quality, operationally clear study synopsis/protocol, ensuring all relevant stakeholders (both internal and external) are involved and contributing.

·         Provide expert clinical operations input into clinical documents related to the drug development process including IBs, INDs, study synopsis & protocols, informed consents, interim and final clinical study reports, applicable sections of NDAs and/or MAAs.

·         Provide strategic and technical guidance to... More Info

Location – Cambridge, MA.

Editas is seeking a Quality Assurance Manager within the Technical Development and Manufacturing team to manage the continued development of the internal Quality Management System. Reporting to the Head of Quality, the QA Manager will be responsible for supporting the development and implementation of the Quality Management System at Editas, eventually becoming responsible for oversight of all internal QMS activities as well as supporting GMP efforts conducted at Contract Manufacturing Organizations (CMO). This is an opportunity for an individual experienced in the drug development environment and, more specifically, GMP documentation requirements, to step in and manage a developing and early stage QMS while having exposure to broader QA responsibilities and significant QA skill set development.

This position's responsibilities include but are not limited to: overseeing all internal and external quality assurance activities including: manage the evolving internal document management system, provide compliance oversight to applicable internal activities, maintain internal documentation processing functions and organizational records management. In addition, the qualified candidate will be expected to identify gaps in the current quality system, propose viable solutions and lead the process for improvement. This position will eventually also function as a QA lead on various project teams.

Key Responsibilities:

·         Process internal controlled documents including but not limited to: SOP’s, forms, templates, internal reports, engineering documents, etc.

·         Assist with SOP and other controlled document generation including authoring revisions, QA review, word processing... More Info

Location - Cambridge, MA.

Editas is seeking Associate Director/Director within the Technical Development and Manufacturing team to lead the Quality Control function and support Editas’ engineered cell and viral vector products that incorporate CRISPR gene-editing technologies. Reporting to the Head of Quality, the qualified candidate will be responsible for overseeing Quality Control activities at the company’s Contract Manufacturing Organizations (CMOs) and Contract Testing Organizations (CTOs), as well as developing an internal QC analytical laboratory. 

This position's responsibilities include but are not limited to: overseeing all internal and external quality control activities including testing and releases of raw materials, intermediates and APIs, supporting IND enabling and GMP production activities, executing proper life-cycle management of analytical methods (i.e. validation, transfer, review, approval, changes), leading OOS/OOT investigations, manage stability programs and ensure compliance to the applicable compendial and regulatory requirements. The AD/Director of QC also ensures compliance of the analytical laboratories and operations to the most current data integrity requirements, drives continuous improvement and implementation of industry best practices to maximize efficiency.

Key Responsibilities:

·         Plan, coordinate, and manage routine testing of in-process, final product and stability study samples in accordance with Standard Operating Procedures and approved methods (HPLC, Q-PCR, activity assays, cell-based bioassays, Osmolality, pH, ELISA, etc.)

·         Coordinate with the Analytical Methods Development group to develop, review and approve the phase appropriate qualification/validation of analytical procedures and the transfer of such procedures into QC or to external laboratories

·        Work within a cross-functional team to develop cellular assays to support gene-edited cell therapy programs at Editas, with a focus on development of flow cytometry panels

·        Conduct hands-on laboratory research activities to develop analytical test methods for cellular in-process and release testing to support manufacturing for clinical trials

·        Write test methods,  develop controls, trend data, and train other scientists on... More Info

Location - Cambridge, MA

Editas Medicine is a transformative genome editing company with a mission to translate its gene editing technology into a novel class of human therapeutics that enable precise and corrective genome level molecular modification to treat the underlying cause of a broad range of diseases.

This new role on the Editas Manufacturing team provides a unique opportunity to contribute to the clinical translation of CRISPR technology by managing efforts that support the development and operationalization of Editas’ clinical programs.

Key Responsibilities:

·        Serve as externally-facing point of contact for select vendors and contract manufacturing organizations

·        Responsible for outsourced manufacturing of select materials to support Editas’ clinical programs

·        Identify vendor ecosystems, develop and submit RFPs, perform site visits, and select vendors in accordance with program timeline and budget

·        Manage the review and implementation of contractual quality and legal agreements

·        Develop, socialize, and manage project plans, budgets, and timelines

·More Info

Location - Cambridge, MA

Editas Medicine is a transformative genome editing company with a mission to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level.

Editas is seeking a Lead Scientist with a focus on research and development of CRISPR/Cas9-based anti-viral therapies.

The candidate will lead the virology discovery group and provide scientific expertise and guidance for disease/target selection, assay design and implementation, candidate selection, therapeutic delivery and transition to early clinical development. 

The successful candidate will demonstrate knowledge in immunology, virology, molecular and cellular biology, with demonstrated expertise in both in vitro cellular and in vivo models is essential.  Working experience with gene editing are desirable but not essential.

Key Responsibilities:

·        Develop therapeutic hypotheses and experimental cellular therapies based on these hypotheses addressing unmet needs in infectious disease

·        Lead a cross functional team of scientists to discover novel therapies from project initiation to development candidate nomination

·        Work effectively with preclinical and clinical teams to transition project to development

·        More Info

Location - Cambridge, MA

We are seeking a highly motivated and innovative research associate with experience in molecular biology, cell biology, and bioinformatics. The successful candidate will contribute as part of a multidisciplinary team to improve gene-editing based therapeutics by developing techniques and researching new understandings in RNA folding and engineering. The successful candidate is expected to have proven practical experience in creating and analyzing next-generation sequencing data sets from mammalian cell culture experiments using cutting edge molecular biology techniques. RNA and cell culture experience in immortalized cell lines is expected. The candidate should be a scientifically motivated self-started, capable of independently conceiving, conducting, and critically analyzing his/her own innovative research with minimal supervision. Strong presentation skills, communication, and the ability to work in a fast-paced and team-oriented environment will also be vital.

Location - Cambridge, MA

Editas Medicine is a transformative genome editing company with a mission to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level.

Editas is seeking a Scientist/Senior Scientist with a focus on research and development of CRISPR/Cas9-based ex vivo cellular therapies.

The candidate will be part of the ex vivo discovery group that is responsible for discovering T cell and non-T cell experimental medicines for oncology and immunomodulation.  The successful candidate will interact effectively with the research and platform groups, as well as external collaborators.  The individual will provide scientific expertise and guidance for target selection, early research to candidate selection, and transition to early clinical development. 

A successful candidate will demonstrate extensive knowledge in molecular and cellular pathways in immunology and oncology.  Experience with cellular models is essential.  Working experience with gene editing, in vivo models, and cell manufacture are desirable but not essential.

Key Responsibilities:

·        Develop therapeutic hypotheses and experimental cellular therapies based on these hypotheses that address unmet needs in immunology and/or oncology

·        Lead a cross functional team of scientists to discovery novel cell-based therapies from project initiation to development candidate nomination

·More Info

Location - Cambridge, MA

Editas Medicine is a transformative genome editing company with a mission to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective genome level molecular modification to treat the underlying cause of a broad range of diseases.

This new role on the Technical Development and Manufacturing team provides a unique opportunity to contribute to Editas’ efforts to develop safe and effective cellular therapies using CRISPR-based gene editing technologies. We are seeking a talented and highly-motivated individual to perform experiments that generate data to guide development of processing methods and standard operating procedures (SOPs) for the preparation of cellular therapies for translational clinical studies. Candidate must be experienced with aseptic technique and be versatile to assist in the development of processes for autologous or normal donor cellular products derived from different lineages of cells (T cells, HSCs, etc.).

Key Responsibilities:

·        Perform experimentation to develop cellular processes to support gene-edited cell therapy programs at Editas

·        Assist in data compilation, analysis, and drafting technical reports to support developed cellular processes for clinical manufacturing

·        Work with Analytical Development to generate and analyze data to develop understanding of most relevant critical quality attributes of cellular products to guide safe and effective clinical testing and process control strategies

More Info

Location - Cambridge, MA

Editas is seeking an innovative and highly motivated scientist to lead development of iPSC and organotypic cultures supporting CRISPR/Cas9-based therapies.

This individual will report to the Sr Director Ocular Disease and lead a team to develop patient derived iPSC and organotypic cultures supporting development of CRISPR/Cs9 ocular therapies. The individual will work collaboratively with internal multi-disciplinary team members and external partners to drive and deliver results on timelines, and present results both internally and externally, including publications.

The successful candidate will have strong subject matter expertise in ocular and cellular biology, iPSC and organotypic cultures. The candidate will possess leadership skills, including the ability to lead a program team and work in a matrix organization. The candidate will also have excellent behaviors consistent with the Editas culture.

Key Responsibilities:

·        Develop iPSC from patient population(s) and conduct POC for gene editing targets

·        Develop, optimize and implement organotypic cultures representative of ocular monogenetic disease and evaluate CRISPR/Cas9 technology in reversal of disease phenotypes

·        Provide molecular and cellular biology scientific oversight for ongoing programs ensuring robust processes are in place to support preclinical and clinical development initiatives

·More Info

Location - Cambridge, MA

Editas Medicine is a transformative genome editing company with a mission to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level.

We are seeking a talented and passionate individual who can thrive in a dynamic, fast-paced, team-oriented and collaborative environment to be part of our success.

The VP of Clinical Development is responsible for leading clinical development activities related to Editas’ pipeline of cell therapy products that have been genetically modified ex vivo using CRISPR for hematological and immunological indications. This cross-functional role involves providing strategic medical and clinical trial expertise input into development programs, preparing clinical trial and regulatory documents, building strong relationships with key opinion leaders, and communicating development plans and study results internally and externally.

This position requires a strong clinical and scientific background, preferably in hematology, oncology, transplantation, and/or immunology.  Knowledge of gene therapy and orphan disease drug development is beneficial. The candidate should have relevant clinical practice experience and an understanding of genetic concepts and molecular biology laboratory techniques.  The candidate should be experienced designing and running clinical trials and interacting with regulatory authorities.  The candidate should be able to clearly communicate concepts and information in writing and via formal presentations to scientific and medical experts internal and external to the company. The VP of Clinical Development should think creatively, function independently, provide strategic insights, and have a thorough knowledge of the activities and procedures involved in clinical drug development, including GCP, ICH, and HIPAA. 

More Info

Location - Cambridge, MA

Editas Medicine is a transformative genome editing company with a mission to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level. 

The successful candidate will lead the Bioanalytical group accountable for timely and effective bioanalytical support for all programs in preclinical and clinical development, balance long-term strategy with tactical and detailed technical decision-making.  This individual will develop and implement strategic program plans and is responsible for design, technical oversight, outsourcing, technology transfer, validation, and documentation for Regulatory submission purposes of bioanalytical methods including ELISA, Luminex, ADA, NAb, ELISPOT, Biodistribtuion etc. The individual will actively participate in program teams, as well as collaborate effectively across functions. The successful candidate shall demonstrate a proven track record in development experience with biologics, nucleic acid-based, or gene therapy products through IND/BLA and solid understanding of FDA/EMA guidelines.  This individual will be highly analytical, goal-oriented, and timeline sensitive while maintaining high quality standards and process.

Key Responsibilities:

·        Develop and implement bioanalytical strategy in support of development of viral (AAV) and non-viral delivered CRISPR medicine

·        Design, execute, interpret and report bioanalytical studies to support drug candidate validation in late-stage research, preclinical and clinical development at all stages

·More Info

Location - Cambridge, Ma

Editas is seeking a Head of Immuno-Oncology to lead a group of biologists developing cell-based immunotherapies primarily for immunologic diseases using CRISPR/Cas9 technology.

This individual will report to Chief Scientific Officer, and lead a group of 12 biologists to develop cell-based therapies. The individual will be responsible for developing the discovery biology. The individual will then work collaboratively with internal multi-disciplinary team members and external partners to initiate programs consistent with the strategy, establish and deliver results on timelines, ensure that pharmacology and safety packages are fit for purpose, and present results both internally and externally, including publications.

The successful candidate shall have a strong technical background in T cell immunology for infectious diseases or autoimmune diseases, cell-based therapies, and drug discovery. The candidate will possess strong leadership skills, including the ability to develop talent and lead in a matrix organization. The candidate will also have excellent behaviors that exemplify Editas culture.

Key Responsibilities:

·        Develop immunotherapy strategy with a focus on disease biology

·        Initiate and drive discovery programs on cell-based therapies primarily for immunologic diseases using CRISPR/Cas9 technology

·        Provide strong scientific oversight of ongoing programs ensuring that robust pharmacologic and safety package are created that support clinical... More Info